Cargando…

Clinical and Immunological Markers of Dengue Progression in a Study Cohort from a Hyperendemic Area in Malaysia

BACKGROUND: With its elusive pathogenesis, dengue imposes serious healthcare, economic and social burden on endemic countries. This study describes the clinical and immunological parameters of a dengue cohort in a Malaysian city, the first according to the WHO 2009 dengue classification. METHODOLOGY...

Descripción completa

Detalles Bibliográficos
Autores principales: Rathakrishnan, Anusyah, Klekamp, Benjamin, Wang, Seok Mui, Komarasamy, Thamil Vaani, Natkunam, Santha Kumari, Sathar, Jameela, Azizan, Azliyati, Sanchez-Anguiano, Aurora, Manikam, Rishya, Sekaran, Shamala Devi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960168/
https://www.ncbi.nlm.nih.gov/pubmed/24647042
http://dx.doi.org/10.1371/journal.pone.0092021
_version_ 1782308129657061376
author Rathakrishnan, Anusyah
Klekamp, Benjamin
Wang, Seok Mui
Komarasamy, Thamil Vaani
Natkunam, Santha Kumari
Sathar, Jameela
Azizan, Azliyati
Sanchez-Anguiano, Aurora
Manikam, Rishya
Sekaran, Shamala Devi
author_facet Rathakrishnan, Anusyah
Klekamp, Benjamin
Wang, Seok Mui
Komarasamy, Thamil Vaani
Natkunam, Santha Kumari
Sathar, Jameela
Azizan, Azliyati
Sanchez-Anguiano, Aurora
Manikam, Rishya
Sekaran, Shamala Devi
author_sort Rathakrishnan, Anusyah
collection PubMed
description BACKGROUND: With its elusive pathogenesis, dengue imposes serious healthcare, economic and social burden on endemic countries. This study describes the clinical and immunological parameters of a dengue cohort in a Malaysian city, the first according to the WHO 2009 dengue classification. METHODOLOGY AND FINDINGS: This longitudinal descriptive study was conducted in two Malaysian hospitals where patients aged 14 and above with clinical symptoms suggestive of dengue were recruited with informed consent. Among the 504 participants, 9.3% were classified as non-dengue, 12.7% without warning signs, 77.0% with warning signs and 1.0% with severe dengue based on clinical diagnosis. Of these, 37% were misdiagnosed as non-dengue, highlighting the importance of both clinical diagnosis and laboratory findings. Thrombocytopenia, prolonged clotting time, liver enzymes, ALT and AST served as good markers for dengue progression but could not distinguish between patients with and without warning signs. HLA-A*24 and -B*57 were positively associated with Chinese and Indians patients with warning signs, respectively, whereas A*03 may be protective in the Malays. HLA-A*33 was also positively associated in patients with warning signs when compared to those without. Dengue NS1, NS2A, NS4A and NS4B were found to be important T cell epitopes; however with no apparent difference between with and without warning signs patients. Distinction between the 2 groups of patients was also not observed in any of the cytokines analyzed; nevertheless, 12 were significantly differentially expressed at the different phases of illness. CONCLUSION: The new dengue classification system has allowed more specific detection of dengue patients, however, none of the clinical parameters allowed distinction of patients with and without warning signs. While the HLA-A*33 may be predictive marker for development of warning signs; larger studies will be needed to support this findings.
format Online
Article
Text
id pubmed-3960168
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39601682014-03-24 Clinical and Immunological Markers of Dengue Progression in a Study Cohort from a Hyperendemic Area in Malaysia Rathakrishnan, Anusyah Klekamp, Benjamin Wang, Seok Mui Komarasamy, Thamil Vaani Natkunam, Santha Kumari Sathar, Jameela Azizan, Azliyati Sanchez-Anguiano, Aurora Manikam, Rishya Sekaran, Shamala Devi PLoS One Research Article BACKGROUND: With its elusive pathogenesis, dengue imposes serious healthcare, economic and social burden on endemic countries. This study describes the clinical and immunological parameters of a dengue cohort in a Malaysian city, the first according to the WHO 2009 dengue classification. METHODOLOGY AND FINDINGS: This longitudinal descriptive study was conducted in two Malaysian hospitals where patients aged 14 and above with clinical symptoms suggestive of dengue were recruited with informed consent. Among the 504 participants, 9.3% were classified as non-dengue, 12.7% without warning signs, 77.0% with warning signs and 1.0% with severe dengue based on clinical diagnosis. Of these, 37% were misdiagnosed as non-dengue, highlighting the importance of both clinical diagnosis and laboratory findings. Thrombocytopenia, prolonged clotting time, liver enzymes, ALT and AST served as good markers for dengue progression but could not distinguish between patients with and without warning signs. HLA-A*24 and -B*57 were positively associated with Chinese and Indians patients with warning signs, respectively, whereas A*03 may be protective in the Malays. HLA-A*33 was also positively associated in patients with warning signs when compared to those without. Dengue NS1, NS2A, NS4A and NS4B were found to be important T cell epitopes; however with no apparent difference between with and without warning signs patients. Distinction between the 2 groups of patients was also not observed in any of the cytokines analyzed; nevertheless, 12 were significantly differentially expressed at the different phases of illness. CONCLUSION: The new dengue classification system has allowed more specific detection of dengue patients, however, none of the clinical parameters allowed distinction of patients with and without warning signs. While the HLA-A*33 may be predictive marker for development of warning signs; larger studies will be needed to support this findings. Public Library of Science 2014-03-19 /pmc/articles/PMC3960168/ /pubmed/24647042 http://dx.doi.org/10.1371/journal.pone.0092021 Text en © 2014 Rathakrishnan et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Rathakrishnan, Anusyah
Klekamp, Benjamin
Wang, Seok Mui
Komarasamy, Thamil Vaani
Natkunam, Santha Kumari
Sathar, Jameela
Azizan, Azliyati
Sanchez-Anguiano, Aurora
Manikam, Rishya
Sekaran, Shamala Devi
Clinical and Immunological Markers of Dengue Progression in a Study Cohort from a Hyperendemic Area in Malaysia
title Clinical and Immunological Markers of Dengue Progression in a Study Cohort from a Hyperendemic Area in Malaysia
title_full Clinical and Immunological Markers of Dengue Progression in a Study Cohort from a Hyperendemic Area in Malaysia
title_fullStr Clinical and Immunological Markers of Dengue Progression in a Study Cohort from a Hyperendemic Area in Malaysia
title_full_unstemmed Clinical and Immunological Markers of Dengue Progression in a Study Cohort from a Hyperendemic Area in Malaysia
title_short Clinical and Immunological Markers of Dengue Progression in a Study Cohort from a Hyperendemic Area in Malaysia
title_sort clinical and immunological markers of dengue progression in a study cohort from a hyperendemic area in malaysia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960168/
https://www.ncbi.nlm.nih.gov/pubmed/24647042
http://dx.doi.org/10.1371/journal.pone.0092021
work_keys_str_mv AT rathakrishnananusyah clinicalandimmunologicalmarkersofdengueprogressioninastudycohortfromahyperendemicareainmalaysia
AT klekampbenjamin clinicalandimmunologicalmarkersofdengueprogressioninastudycohortfromahyperendemicareainmalaysia
AT wangseokmui clinicalandimmunologicalmarkersofdengueprogressioninastudycohortfromahyperendemicareainmalaysia
AT komarasamythamilvaani clinicalandimmunologicalmarkersofdengueprogressioninastudycohortfromahyperendemicareainmalaysia
AT natkunamsanthakumari clinicalandimmunologicalmarkersofdengueprogressioninastudycohortfromahyperendemicareainmalaysia
AT satharjameela clinicalandimmunologicalmarkersofdengueprogressioninastudycohortfromahyperendemicareainmalaysia
AT azizanazliyati clinicalandimmunologicalmarkersofdengueprogressioninastudycohortfromahyperendemicareainmalaysia
AT sanchezanguianoaurora clinicalandimmunologicalmarkersofdengueprogressioninastudycohortfromahyperendemicareainmalaysia
AT manikamrishya clinicalandimmunologicalmarkersofdengueprogressioninastudycohortfromahyperendemicareainmalaysia
AT sekaranshamaladevi clinicalandimmunologicalmarkersofdengueprogressioninastudycohortfromahyperendemicareainmalaysia